Texas Healthcare Portfolio 2
This is a sample of a Delaware Statutory Trust offering, drawn from a past offering that is already fully subscribed and shown here for illustration. DSTs are illiquid private placements offered under Reg D to accredited investors only. The figures below are sourced from the sponsor’s Private Placement Memorandum. Year-one cash-flow, cap-rate, and DSCR figures are projections, not guarantees. Loss of principal is possible.
About this offering
Inland Texas Healthcare Portfolio 2 is an all-cash investment into three separate medical office buildings located in Arlington and Houston. Debt-free structure means no scheduled refinance over the hold.
Key metrics
- Year 1 Cash Flow
- 5.08%
- Year 1 Cap Rate
- 5.65%
- Investor Purchase Price
- $55.02M
- Year 1 DSCR
- —
- Hold Period DSCR
- —
Debt structure
- Loan Amount
- —
- Lender
- —
- Program
- —
- Interest Rate
- —
- LTV
- 0.00%
- Term
- —
- Interest Only
- —
- Amortization
- —
Specifications
- Occupancy
- 100.00%
Principal risks
- R01The Houston properties are not certified by Medicare, making them an out-of-network provider. This could decrease their chances of being reimbursed and limits the potential patient pool.
- R02The sponsor is not placing a large amount of money into their reserve accounts, which could make it hard to cover tenant improvements.
- R03All of the tenants are non-investment grade.
Property imagery
Inland
According to the sponsor's website: "The Inland Real Estate Group of Companies, Inc. (“Inland”), is an industry leader and one of the nation's largest commercial real estate and finance organizations. As a business incubator, we specialize in creating, developing and supporting Inland member companies that provide commercial real estate-related services and alternative investment funds, including limited partnerships, institutional funds and non-listed and listed REITs."
Explore current offerings like Texas Healthcare Portfolio 2
This offering is fully subscribed and shown for illustration. A coordinator can introduce current offerings with a similar profile to accredited investors.